Scand J Rheumatol. 1992;21(1):5-9.

Serum levels of aminoterminal type III procollagen peptide and hyaluronan predict mortality in systemic sclerosis.

Scheja A, Akesson A, Hørslev-Petersen K.

Source

Department of Rhematology, University Hospital, Lund, Sweden.

Abstract

Systemic sclerosis (SSc) is characterized by an excessive accumulation of collagen in skin and internal organs and increased serum concentrations of different connective tissue metabolites have been reported. In this study of 82 patients with SSc, serum concentrations of aminoterminal type III procollagen peptide (PIIINP), smaller PIIINP-related antigens (Fab PIIINP) and hyaluronan (HA) were increased as compared to healthy controls matched for age and sex. Patients with a shorter disease duration (less than 3 years) had higher serum levels of PIIINP and Fab PIIINP than patients with a longer disease duration. The highest serum concentrations of PIIINP and HA were seen in seven patients who died within 2 years.

PMID:: 1570489; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Scleroderma - MedlinePlus Health Information

Molecular Biology Databases

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Carboxyterminal type I procollagen peptide concentrations in systemic sclerosis: higher levels in early diffuse disease. [Br J Rheumatol. 1993]
Carboxyterminal type I procollagen peptide concentrations in systemic sclerosis: higher levels in early diffuse disease.
Scheja A, Hellmer G, Wollheim FA, Akesson A. Br J Rheumatol. 1993 Jan; 32(1):59-62.
Type III procollagen N-terminal propeptide, soluble interleukin-2 receptor, and von Willebrand factor in systemic sclerosis. [Clin Exp Rheumatol. 2001]
Type III procollagen N-terminal propeptide, soluble interleukin-2 receptor, and von Willebrand factor in systemic sclerosis.
Lee YJ, Shin KC, Kang SW, Lee EB, Kim HA, Song YW. Clin Exp Rheumatol. 2001 Jan-Feb; 19(1):69-74.
Different effects of thyroid disease on serum levels of procollagen III N-peptide and hyaluronic acid. [J Clin Endocrinol Metab. 1990]
Different effects of thyroid disease on serum levels of procollagen III N-peptide and hyaluronic acid.
Faber J, Hørslev-Petersen K, Perrild H, Lorenzen I. J Clin Endocrinol Metab. 1990 Oct; 71(4):1016-21.
Review Aminoterminal propeptide of type III procollagen in ovarian cancer. A review. [Acta Obstet Gynecol Scand Supp...]
Review Aminoterminal propeptide of type III procollagen in ovarian cancer. A review.
Risteli L, Risteli J, Puistola U, Tomás C, Zhu GG, Kauppila A. Acta Obstet Gynecol Scand Suppl. 1992; 155:99-103.
Review The aminoterminal propeptide of type III procollagen. Studies on physiology and pathophysiology. [Dan Med Bull. 1997]
Review The aminoterminal propeptide of type III procollagen. Studies on physiology and pathophysiology.
Jensen LT. Dan Med Bull. 1997 Feb; 44(1):70-8.

See reviews... See all...

Cited by 1 PubMed Central article

Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma). [Arthritis Res. 2001]
Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma).
Scheja A, Akesson A, Geborek P, Wildt M, Wollheim CB, Wollheim FA, Vischer UM. Arthritis Res. 2001; 3(3):178-82. Epub 2001 Feb 19.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Serum levels of aminoterminal type III procollagen peptide and hyaluronan predic...
Serum levels of aminoterminal type III procollagen peptide and hyaluronan predict mortality in systemic sclerosis.
Scand J Rheumatol. 1992 ;21(1):5-9.

PubMed
Upregulation of A2A adenosine receptor expression by TNF-alpha in PBMC of patien...
Upregulation of A2A adenosine receptor expression by TNF-alpha in PBMC of patients with CHF: a regulatory mechanism of inflammation.
J Card Fail. 2005 Feb ;11(1):67-73.

PubMed
Androgen treatment prevents diabetes in nonobese diabetic mice.
Androgen treatment prevents diabetes in nonobese diabetic mice.
J Exp Med. 1992 May 1 ;175(5):1409-12.

PubMed
The role of B cells in the pathogenesis of rheumatoid arthritis.
The role of B cells in the pathogenesis of rheumatoid arthritis.
J Rheumatol Suppl. 2005 Feb ;73:14-8; discussion 29-30.

PubMed
IgG antibody response to polyethylene glycol-modified adenosine deaminase in pat...
IgG antibody response to polyethylene glycol-modified adenosine deaminase in patients with adenosine deaminase deficiency.
J Clin Invest. 1992 May ;89(5):1643-51.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Serum levels of aminoterminal type III procollagen peptide and hyaluronan predict mortality in systemic sclerosis.

Source

Abstract

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Libraries

Supplemental Content

Save items

Related citations in PubMed

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information